Stock Price
4.64
Daily Change
-0.08 -1.59%
Monthly
13.33%
Yearly
85.27%
Q1 Forecast
4.59

EDAP TMS reported EUR21.81M in Operating Expenses for its fiscal quarter ending in June of 2025.





Operating Expenses Change Date
AngioDynamics USD 81.98M 1.96M Feb/2025
Boston Scientific USD 4.04B 18M Dec/2025
EDAP TMS EUR 21.81M 2.26M Jun/2025
Henry Schein USD 3.14B 77M Sep/2025
Medtronic USD 7.28B 16M Dec/2025
Veracyte USD 108.76M 7.09M Sep/2025